Log in
Enquire now
Viatris

Viatris

Viatris is a small Molecules, Generics founded in 1961.

OverviewStructured DataIssuesContributors

All edits by  Liliya Basenkova 

Edits on 20 Feb, 2022
Liliya Basenkova profile picture
Liliya Basenkova
edited on 20 Feb, 2022
Edits made to:
Infobox (+2 properties)
Infobox
Instagram
https://instagram.com/crunchbase
Facebook
https://www.facebook.com/viatrisinc/
Liliya Basenkova profile picture
Liliya Basenkova
edited on 20 Feb, 2022
Edits made to:
Table (+1 rows) (+4 cells) (+206 characters)
Table

Title
Date
Link

Viatris Announces 9% Dividend Increase, Fourth Consecutive Quarterly Dividend

06.01.2022

https://newsroom.viatris.com/2022-01-06-Viatris-Announces-9-Dividend-Increase,-Fourth-Consecutive-Quarterly-Dividend

Liliya Basenkova profile picture
Liliya Basenkova
edited on 20 Feb, 2022
Edits made to:
Table (+2 rows) (+8 cells) (+809 characters)
Table

Title
Date
Link

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch

18.01.2022

https://newsroom.viatris.com/2022-01-18-Mylan-Pharmaceuticals-Inc-,-a-Viatris-Company,-Conducting-Voluntary-Recall-of-One-Batch-of-Semglee-R-insulin-glargine-injection-,-100-units-mL-U-100-,-3-mL-Prefilled-Pens,-Due-to-the-Potential-for-a-Missing-Label-in-the-Batch

Viatris is First to Receive FDA Approval of Generic Restasis® (Cyclosporine Ophthalmic Emulsion 0.05%) to Treat Dry Eye Disease

03.02.2022

https://newsroom.viatris.com/2022-02-03-Viatris-is-First-to-Receive-FDA-Approval-of-Generic-Restasis-R-Cyclosporine-Ophthalmic-Emulsion-0-05-to-Treat-Dry-Eye-Disease

Liliya Basenkova profile picture
Liliya Basenkova
edited on 19 Feb, 2022
Edits made to:
Table (+1 rows) (+4 cells) (+297 characters)
Table

Title
Date
Link

Viatris to Host Virtual Investor Event and Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

04.02.2022

https://newsroom.viatris.com/2022-02-04-Viatris-to-Host-Virtual-Investor-Event-and-Report-Fourth-Quarter-and-Full-Year-2021-Financial-Results-on-February-28,-2022

Liliya Basenkova profile picture
Liliya Basenkova
edited on 19 Feb, 2022
Edits made to:
Table (+1 rows) (+3 cells) (+79 characters)
Table

Name
Role
LinkedIn

Sanjeev Narula

CFO

https://www.viatris.com/en/about-us/our-leaders/sanjeev-narula

Liliya Basenkova profile picture
Liliya Basenkova
edited on 19 Feb, 2022
Edits made to:
Table (+1 rows) (+3 cells) (+79 characters)
Table

Name
Role
LinkedIn

Rajiv Malik

President

https://www.viatris.com/en/about-us/our-leaders/rajiv-malik

Liliya Basenkova profile picture
Liliya Basenkova
edited on 19 Feb, 2022
Edits made to:
Table (+1 rows) (+3 cells) (+83 characters)
Table

Name
Role
LinkedIn

Michael Goettler

CEO

https://www.viatris.com/en/about-us/our-leaders/michael-goettler

Liliya Basenkova profile picture
Liliya Basenkova
edited on 19 Feb, 2022
Edits made to:
Article (+652 characters)
Table (+1 rows) (+3 cells) (+95 characters)
Article

Viatris was formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~40,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide.

Our global portfolio includes best-in-class, iconic brand name products as well as global key brands; generics, including branded and complex generics; biosimilars; and over-the-counter offerings across a wide range of therapeutic areas. We are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.

Table

Name
Role
LinkedIn

Robert J. Coury

Executive Chairman

https://www.viatris.com/en/about-us/our-leaders/robert-j-coury

Find more companies like Viatris

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.